Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive Disease.
Kluge R, Wittig T, Georgi TW, Kurch L, Sabri O, Wallace WH, Klekawka T, Fernández-Teijeiro A, Ceppi F, Karlén J, Pears J, Cepelová M, Fosså A, Beishuizen A, Hjalgrim LL, Körholz D, Mauz-Körholz C, Hasenclever D.
Kluge R, et al. Among authors: korholz d.
J Nucl Med. 2021 Mar;62(3):338-341. doi: 10.2967/jnumed.120.247924. Epub 2020 Aug 6.
J Nucl Med. 2021.
PMID: 32764122
Free article.